Lab21 has announced that its immunodiagnostic division has entered into a distribution agreement with Inverness Medical India to supply more than 500,000 TPHA kits for the diagnosis of syphilis.
This initial contract will see approximately USD1.1m of reagents supplied into the Indian healthcare market over the next 18 months.
